FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction...

atai Life Sciences Secures Term Loan Facility for up to $175...

Field Trip Announces Closing of Plan of Arrangement and $19.9 Million...

PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support...

Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed...

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved...

MindMed Strengthens Board with Appointment of Two New Independent Directors

Opinions | Hallucinations of Meaning: If you can lie, so can...

PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act,...

Load more